Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
Bioorg Khim ; 38(3): 306-14, 2012.
Article in Russian | MEDLINE | ID: mdl-22997702

ABSTRACT

Multiple Sclerosis (MS) is a serve autoimmune neurodegenerative disease. Development of innovative approaches of MS treatment is of a high priority in the modern immunology and pharmacy. In the present study we showed high therapeutic efficiency of immunodominant peptides of myelin basic protein (MBP) incorporated into the monolayer mannosylated liposomes on the development of experimental autoimmune encephalomyelitis (EAE) in DA rats. MBP is a component ofoligodendrocytes' membrane, which form axonal sheath, and is one of the major autoantigens in MS. We analyzed binding pattern ofanti-MBP autoantibodies from MS patients using previously designed MBP epitope library. Utilizing the same approach we investigated pool of anti-MBP antibodies from SJL/J and C57/BL6 mice and DA rats with induced EAE. The most relevant rodent model to MS was EAE in DA rats according to the autoantibodies' binding pattern. We selected three immunodominant MBP fragments encapsulated in monolayer mannosylated liposomes for the following treatment of verified DA rodent model. MBP fragment 46-62 was the most effective in reducing of the first EAE attack, whereas MBP 124-139 and 147-160 inhibited development of pathology during remission stage. Simultaneous administration of these peptides in liposomes significantly decreased level of anti-MBP antibodies. Synergetic therapeutic effect of MBP fragments reduced integral disease score by inhibiting first EAE wave and subsequent remission, thus, our findings disclosure novel approaches for efficient treatment of Multiple Sclerosis.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/drug therapy , Immunodominant Epitopes/administration & dosage , Multiple Sclerosis/drug therapy , Myelin Basic Protein/administration & dosage , Nanocapsules/administration & dosage , Peptide Fragments/administration & dosage , Adult , Amino Acid Sequence , Animals , Autoantibodies/immunology , Guinea Pigs , Humans , Immunodominant Epitopes/immunology , Immunodominant Epitopes/therapeutic use , Liposomes , Mice , Mice, Inbred C57BL , Middle Aged , Molecular Sequence Data , Myelin Basic Protein/immunology , Myelin Basic Protein/therapeutic use , Nanocapsules/chemistry , Peptide Fragments/immunology , Peptide Fragments/therapeutic use , Rats , Rats, Inbred Strains
2.
J Exp Med ; 190(6): 749-56, 1999 Sep 20.
Article in English | MEDLINE | ID: mdl-10499913

ABSTRACT

Although it is well established that immature B lymphocytes are exquisitely sensitive to tolerance induction compared with their mature counterparts, the molecular basis for this difference is unknown. We demonstrate that signaling by B cell antigen receptors leads to distinct and mutually exclusive biologic responses in mature and immature B cells: upregulation of CD86, CD69, and MHC class II in mature cells and receptor editing in immature cells. These responses can be induced simply by elevation of intracellular free calcium levels, as occurs after receptor aggregation. Importantly, induction of immature B cell responses requires much smaller increases in intracellular free calcium than does induction of mature B cell responses. These differences in biologic response and sensitivity to intracellular free calcium likely contributes to selective elimination at the immature stage of even those B cells that express low affinity for self-antigens.


Subject(s)
B-Lymphocytes/immunology , Gene Expression Regulation/immunology , Receptors, Antigen, B-Cell/genetics , Animals , Antigens, CD/genetics , Antigens, CD/immunology , Antigens, Differentiation, T-Lymphocyte/genetics , Antigens, Differentiation, T-Lymphocyte/immunology , B-Lymphocytes/cytology , B7-2 Antigen , Cell Differentiation/immunology , Histocompatibility Antigens Class II/genetics , Histocompatibility Antigens Class II/immunology , Lectins, C-Type , Membrane Glycoproteins/genetics , Membrane Glycoproteins/immunology , Mice , Mice, Transgenic , RNA Editing/immunology , Receptors, Antigen, B-Cell/immunology , Up-Regulation
3.
Mol Cell Biol ; 13(9): 5255-65, 1993 Sep.
Article in English | MEDLINE | ID: mdl-7689148

ABSTRACT

Transcription factor E2F binds to cellular promoters of certain growth- and cell cycle-controlling genes and forms distinct heteromeric complexes with other nuclear proteins. We show here that alpha and beta interferons (alpha, beta) and interleukin-6 abolished the E2F-containing DNA-binding complexes in Daudi Burkitt lymphoma cells and in M1 myeloblastic cells, which responded to the cytokines by suppression of c-myc transcription. Time kinetics studies showed that the abolishment of E2F complexes coincided with reduction of c-myc expression and that both molecular events preceded the cell cycle block in G0/G1 phase. In contrast, the pattern of E2F complexes remained unchanged in an interferon-treated growth-resistant Daudi cell mutant that displayed relaxed regulation of c-myc. All of the DNA-binding E2F complexes, including those containing the retinoblastoma protein (pRB), cyclin A-p33cdk2, and the free forms of E2F, were reduced by interferons or interleukin-6. Their abolishment was unperturbed by pharmacological treatments that alleviated the cyclin A and pRB responses to interferon. Thus, changes in cyclin A expression and pRB phosphorylation are not primary events that influence the pattern of E2F responses to cytokines. Addition of EDTA to cell extracts of interferon-treated Daudi cells restored the DNA-binding activity of E2F, resulting in the appearance of a single E2F complex that exclusively contained pRB. It is suggested that the regulation of E2F by growth-inhibitory cytokines that induce cell cycle exit takes place at the level of the DNA-binding activity, and by that mean it differs basically from the phase-specific regulation of E2F in cycling cells.


Subject(s)
Carrier Proteins , Cell Cycle Proteins , DNA-Binding Proteins/metabolism , Interferons/pharmacology , Interleukin-6/pharmacology , Transcription Factors/metabolism , Base Sequence , Cell Division , Cell Line , Cyclins/metabolism , E2F Transcription Factors , Edetic Acid/pharmacology , Gene Expression , Genes, myc , Humans , In Vitro Techniques , Magnesium/metabolism , Molecular Sequence Data , Oligodeoxyribonucleotides/chemistry , Promoter Regions, Genetic , Proto-Oncogene Proteins c-myc/metabolism , RNA, Messenger/genetics , Retinoblastoma Protein/metabolism , Retinoblastoma-Binding Protein 1 , Transcription Factor DP1
4.
Mol Cell Biol ; 16(7): 3934-44, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8668211

ABSTRACT

Alpha interferon is a potent growth inhibitor of Daudi Burkitt's lymphoma cells. We show here that alpha-interferon signaling interacted simultaneously with several components of the basic cell cycle machinery, causing cells to enter into a state that had many features characteristic of the G0 state. Within a few hours after alpha-interferon treatment, cyclin D3 mRNA and protein levels dropped to undetectable levels and, in parallel, the activities of cyclin A- and cyclin E-associated kinases were significantly reduced. The latter resulted from the rapid alpha-interferon-mediated elimination of cdc25A, a phosphatase that is required for antagonism of negative tyrosine phosphorylation of cdk2 in cyclin-cdk complexes. This regulation represents a novel mechanism through which an external inhibitory cytokine interacts with the cell cycle machinery. At later time points after alpha-interferon treatment, the levels of the 55-kDa slowly migrating hyperphosphorylated form of cyclin E and of cyclin A were also reduced. The antiproliferative effects were reversible, and cultures from which alpha interferon was removed reentered S phase after a lag that typically corresponded to approximately two doubling times. During this lag period, the expression of cyclin D3 and cyclin A, as well as of the cdc25A phosphatase, continued to be switched off, in spite of the removal of alpha interferon from the cell surface. In contrast, c-myc, which represents another downstream target gene that is subjected to negative regulation by alpha interferon, was relieved from suppression much earlier, concomitant with the decay in early signaling of the cytokine. The delayed pattern of cyclin reexpression provides evidence that alpha-interferon signaling imposes a G0-like state on this system.


Subject(s)
Cell Cycle Proteins/biosynthesis , Cell Cycle/drug effects , Cyclins/biosynthesis , Gene Expression Regulation, Neoplastic/drug effects , Interferon-alpha/pharmacology , Phosphoprotein Phosphatases/biosynthesis , Burkitt Lymphoma , Cell Cycle Proteins/metabolism , Cell Division/drug effects , Cell Line , Cyclin D3 , Cyclin-Dependent Kinases/metabolism , Cyclins/isolation & purification , GTP-Binding Proteins/biosynthesis , Humans , Kinetics , Phosphoprotein Phosphatases/metabolism , Resting Phase, Cell Cycle , Suppression, Genetic , Tetradecanoylphorbol Acetate/pharmacology , Time Factors , Tumor Cells, Cultured , cdc25 Phosphatases
5.
Curr Top Microbiol Immunol ; 245(2): 57-71, 2000.
Article in English | MEDLINE | ID: mdl-10533318

ABSTRACT

This review touches on only a small part of the complex biology of B cells, but serves to illustrate the point that the antigen receptor is the most important of many cell-surface receptors affecting cell-fate decisions. Receptor expression is necessary, but not sufficient, for cell survival. It is also essential that a B cell's antigen-receptor specificity be appropriate for its environment. The need to balance reactivity with self tolerance has resulted in an intricate feedback control (affected by both the recombinase and cell survival) that regulates independent selection events at the level of the receptor and the cell.


Subject(s)
B-Lymphocytes/physiology , Receptors, Antigen, B-Cell/physiology , Signal Transduction/physiology , Animals , B-Lymphocytes/cytology , Cell Differentiation , Cell Survival , Humans , Immunoglobulin M/physiology , Receptors, Antigen, B-Cell/metabolism
6.
Histol Histopathol ; 20(1): 187-96, 2005 01.
Article in English | MEDLINE | ID: mdl-15578437

ABSTRACT

Recent studies suggest that developmental check-points in B-lymphopoiesis are set in order to test the B cell receptor signaling competence. In these check-points ligand-independent and ligand-dependent receptor signals confer B-lymphopoiesis with positive and negative selection events. As a consequence, B-lymphocytes are forced to make crucial fate decisions to determine developmental progression, survival or apoptosis. In here we review recent progress in unraveling molecular and cellular mechanisms for the role of B cell receptor signaling competence in determination of the B cell fate.


Subject(s)
B-Lymphocytes/immunology , Lymphopoiesis/immunology , Receptors, Antigen, B-Cell/immunology , Signal Transduction/immunology , Animals , Clonal Deletion/immunology , Humans , Ligands
7.
Histol Histopathol ; 18(2): 519-27, 2003 04.
Article in English | MEDLINE | ID: mdl-12647803

ABSTRACT

Homeostasis in the B cell compartment (as well as in T cells) is controlled by tightly regulated selection events. Throughout their life span, B cells are subjected to selection signals determining not only developmental progression, but also maturation and survival. It is now clear that most of these signals require the expression of B cell antigen receptor (or preB receptor) with functional signaling capacity. The administration of numerous mutations into the mouse germline enabled us to identify several checkpoints along the B cell developmental pathway, and provided us with powerful experimental tools to probe for selection events regulating developmental progression. In here, we will discuss recent studies in this field.


Subject(s)
B-Lymphocytes/physiology , Animals , Humans , Mice , Receptors, Antigen, B-Cell/metabolism , Stem Cells/physiology
8.
J Pharm Biomed Anal ; 23(4): 745-55, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10975250

ABSTRACT

CGS 26214 is a racemic compound having cholesterol-lowering activity in rats, dogs, and monkeys. This compound has two equipotent chiral components CGS 28934(-) and CGS 28935(+). An analytical challenge was to develop a sensitive liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the analysis of the chiral components in human plasma following clinical doses of 1 mg or less. Several issues had to be addressed in order to devise a LC/MS/MS assay for the above compounds. First, the compounds were esters and susceptible to hydrolysis under experimental conditions. Second, a lower limit of quantitation (LLOQ) of 0.4 ng/ml was needed. Third, positive electrospray ionization of CGS 26214 did not yield sufficient sensitivity needed for the studies in humans. Consequently, LC/MS/MS conditions were optimized for negative ion mode of detection. Fourth, sample preparation steps proved to be critical in order to reduce the possibility of microbore chiral-HPLC column (100 x 1.0 mm i.d.) obstruction, chromatographic deterioration, and matrix mediated electrospray ion suppression. Although the present method addressed the above challenges, its major drawback was limited sample throughput capability. Nonetheless, the method was successfully applied to generate plasma concentration-time profiles for human subjects after oral doses (0.9 mg) of the racemate as well as the optically pure isomers.


Subject(s)
Glyoxylates/blood , Hypolipidemic Agents/blood , Chromatography, Liquid , Humans , Mass Spectrometry , Quality Control , Reference Standards , Reproducibility of Results , Stereoisomerism
9.
Avian Dis ; 35(1): 17-22, 1991.
Article in English | MEDLINE | ID: mdl-2029251

ABSTRACT

Ultrasonic inactivation of Escherichia coli followed by irradiation was found to be the most efficient method for preparation of an effective vaccine against colibacillosis. Challenge experiments revealed that this vaccine provided the best protection compared with other methods of inactivation: heat, formaldehyde, and irradiation. Preparing the ultrasonicated vaccine from O2:K1 strain increased its range and also supported adequate protection against homologous strain O78:K80. The degree of protection conferred by the vaccine was positively correlated with the antibody titer against E. coli as measured on day of challenge. Low antibody titers detected 5 days post-vaccination resulted in only 20% protection. High antibody titers detected at 8 and 15 days post-vaccination correlated with a low number of chicks with lesions. In each challenged group, the live chicks that did not develop lesions had higher antibody titers than chicks with lesions, revealing a correlation between numbers of chicks with lesions and antibody titers as measured by enzyme-linked immunosorbent assay.


Subject(s)
Bacterial Vaccines , Chickens , Escherichia coli Infections/veterinary , Escherichia coli/immunology , Poultry Diseases/prevention & control , Animals , Antibodies, Bacterial/biosynthesis , Bacterial Vaccines/immunology , Enzyme-Linked Immunosorbent Assay , Escherichia coli Infections/prevention & control , Sonication , Vaccines, Inactivated/immunology
10.
Avian Dis ; 34(1): 58-62, 1990.
Article in English | MEDLINE | ID: mdl-2181997

ABSTRACT

An enzyme-linked immunosorbent assay (ELISA) was modified for detection of antibodies against the two main pathogenic serotypes of Escherichia coli: serotypes O78:K80 and O2:K1. The ELISA was a more sensitive and repeatable test than the indirect hemagglutination test (IHT), which is a common method for detecting antibodies against E. coli. Cross-reactivity between the two strains was measured by reacting antisera of each serotype against homologous and heterologous antigens. The results suggest that aside from similar determinants expressed by the two serotypes, serotype O2:K1 expresses more strain-specific determinants than does O78:K80. Comparison of mean antibody titers of immunized chicks by IHT and ELISA along the primary response revealed that during the first 15 days after immunization with inactivated E. coli, the titers in both tests were parallel. After 15 days post-immunization, antibody titers measured by IHT decreased rapidly, whereas titers measured by ELISA decreased only slightly. In addition, a higher correlation was found between titers detected by ELISA and survival through challenge with E. coli than between titers detected with IHT and survival through challenge. The results suggest that the ELISA is a better test for detection of antibody in flocks suspected of being infected with E. coli.


Subject(s)
Antibodies, Bacterial/analysis , Chickens , Escherichia coli Infections/veterinary , Escherichia coli/immunology , Poultry Diseases/immunology , Animals , Cross Reactions , Enzyme-Linked Immunosorbent Assay , Escherichia coli Infections/immunology , Hemagglutination Tests , Immunoglobulin G/analysis , Immunoglobulin M/analysis , Male
11.
Poult Sci ; 73(6): 843-7, 1994 Jun.
Article in English | MEDLINE | ID: mdl-8072927

ABSTRACT

The effect of dietary vitamin A on antibody production and T cell proliferative response was determined in broilers from 21 to 39 d old. Chicks were fed soybean meal-sorghum diets with levels of supplemented vitamin A from 0 to 13,200 micrograms/kg retinol equivalents from hatching and were immunized with beta-casein at 21 d of age. T cell proliferation response to beta-casein or an acetone precipitate of antigen to Mycobacterium tuberculosis was determined in vitro at 34 to 37 d old. Antibodies to beta-casein in serum were determined every 5 d from 21 d of age. In chicks with no added dietary vitamin A, antibody production and proliferative response were depressed in comparison with chicks receiving vitamin A. Addition of small amounts of vitamin A enhanced the responses; both antibody production and proliferative responses increased with dietary vitamin A until the diet contained 6,660 micrograms/kg, above which the responses decreased. This suggests that maximal immune responses in the chick may be achieved at dietary intakes considerably higher than NRC recommendations.


Subject(s)
Antibodies, Bacterial/immunology , Chickens/immunology , Mycobacterium avium/immunology , T-Lymphocytes/immunology , Vitamin A/administration & dosage , Animal Feed , Animals , Antigens, Bacterial/administration & dosage , Caseins/administration & dosage , Food, Fortified , Injections, Subcutaneous , Leukocyte Count/drug effects , Male , T-Lymphocytes/drug effects , Vitamin A/blood
12.
Waste Manag ; 22(3): 327-33, 2002.
Article in English | MEDLINE | ID: mdl-11952179

ABSTRACT

Elemental mercury, contaminated with radionuclides, presents a waste disposal problem throughout the Department of Energy complex. In this paper we describe a new process to immobilize elemental mercury wastes, including those contaminated with radionuclides, in a form that is non-dispersible, will meet EPA leaching criteria, and has low mercury vapor pressure. In this stabilization and solidification process, elemental mercury is combined with an excess of powdered sulfur polymer cement (SPC) and sulfide additives in a mixing vessel and heated to approximately 40 degrees C for several hours, until all of the mercury is converted into mercuric sulfide (HgS). Additional SPC is then added and the temperature of the mixture raised to 135 degrees C, resulting in a molten liquid which is poured into a mold where it cools and solidifies. The final treated waste was characterized by powder X-ray diffraction and found to be a mixture of the hexagonal and orthorhombic forms of mercuric sulfide. The Toxicity Characteristic Leaching Procedure was used to assess mercury releases, which for the optimized process averaged 25.8 microg/l, with some samples being well below the new EPA Universal Treatment Standard of 25 microg/l. Longer term leach tests were also conducted, indicating that the leaching process was dominated by diffusion. Values for the effective diffusion coefficient averaged 7.6x10(-18) cm2/s. Concentrations of mercury vapor from treated waste in equilibrium static headspace tests averaged 0.6 mg/m3.


Subject(s)
Mercury/chemistry , Polymers/chemistry , Refuse Disposal , Sulfur Compounds/chemistry , Diffusion , Environmental Pollution/prevention & control , Temperature
13.
Prikl Biokhim Mikrobiol ; 26(2): 157-67, 1990.
Article in Russian | MEDLINE | ID: mdl-2195500

ABSTRACT

Data on the composition of major and minor molecular forms of triacylglycerols from edible vegetable oils are reviewed. To estimate the food and biological value of vegetable oils, an attempt was made to classify them according to their triacylglycerol composition.


Subject(s)
Plant Oils/analysis , Triglycerides/analysis
14.
Vopr Pitan ; (5): 57-61, 1979.
Article in Russian | MEDLINE | ID: mdl-574685

ABSTRACT

The content of carcinogenous N-nitrosoamines (N-nitrosodimethylamine, N-nitrosodiethylamine, N-nitrosopiperidine) was determined fluorimetrically (as NBD-amines) in preserved products, food concentrates, dried fruit and mushrooms. No N-nitrosoamines were found in the concentrates and dried products. The content of N-nitrosamines did not exceed 3 g/kg. In some samples its content reached 19 microgram/kg.


Subject(s)
Food Contamination/analysis , Nitrosamines/analysis , Basidiomycota/analysis , Diethylnitrosamine/analysis , Dimethylnitrosamine/analysis , Food Analysis , Food Preservation , Fruit/analysis , Piperidines/analysis , Spectrometry, Fluorescence , Vegetables/analysis
15.
Vopr Pitan ; (6): 64-8, 1978.
Article in Russian | MEDLINE | ID: mdl-726376

ABSTRACT

A spectrofluorometric method of analyzing the carcinogenic N-nitrosoamines in the form of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole derivatives is proposed. The content of nitroso-amines in a number of products of the vegetative origin was determined. In some samples of beetroots, radish and apples dimethyl-nitroso-amine in concentrations of 0.7--1.5 gamma/kg was detected. A conclusion is drawn on a relatively low content of carcinogenic N-nitroso-amines in the products of the vegetable origin.


Subject(s)
Nitrosamines/analysis , Plants, Edible/analysis , Food Analysis/methods , Spectrometry, Fluorescence/methods
16.
Vopr Pitan ; (2): 65-72, 1978.
Article in Russian | MEDLINE | ID: mdl-654211

ABSTRACT

Samples of meat and meat products for the content therein of carcinogenic N-nitrose-amines were subjected to a fluorometric analysis. In case of positive results the presence of NA was confirmed by cromate-mass-spectrometric and/or mass-spectrometric methods. The mean value for the concentrations of dimethyl-nitrose-amine, diethyl-nitrose-amine and nitrose-piperidine in meat products is within the ranges of 1.5-5.4, 1.0-6.1, 0.9-23.4 gamma/kg, respectively. NA was not found in meat.


Subject(s)
Meat Products/analysis , Meat/analysis , Nitrosamines/analysis , Animals , Cattle , Chromatography, Thin Layer/methods , Mass Spectrometry/methods , Spectrometry, Fluorescence/methods , Swine
17.
Vopr Pitan ; (3): 61-5, 1988.
Article in Russian | MEDLINE | ID: mdl-3206860

ABSTRACT

Three criteria have been suggested for the identification of food vegetable oils: the ratio of the summary area of triglyceride peaks and the summary area of the reference peaks; a set of peaks of critical pairs of oil triglycerides and their relationship expressed as the percent of the maximum peak. To prove the correctness of the identification a previously known oil is analyzed and its characteristics are compared to those of the oil under study. A mixture of saturated triglycerides with equivalent carbon numbers 30-56 is used as a reference one. A total of 16 vegetable oils have been identified with the use of the method suggested.


Subject(s)
Dietary Fats/analysis , Plant Oils/analysis , Triglycerides/analysis , Chromatography, Gas/methods , Humans , Nutritive Value
SELECTION OF CITATIONS
SEARCH DETAIL